Dextranomer

DB13560InvestigationalSmall molecule

Dextranomer: Overview.

Resolves to

Compound
UNII30KXI0TVD3CAS56087-11-7
Clinical / RWD
RxNorm22708ATCD03AX02

What you can answer from here — as of March 06, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in

Which companies are running trials of Dextranomer, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In